Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

FDA grants priority review for Pegasys combination treatment

July 17, 2002

Amrad discontinues development of AM-365

July 15, 2002

Chiron licenses hepatitis C targets to Abbott

July 15, 2002

Novel anti-H. pylori agents claimed in Shionogi patent

July 12, 2002

Phase I trial initiated with visilizumab in patients with ulcerative colitis

July 12, 2002

Santarus and TAP sign license agreement related to GI diseases

July 12, 2002

Natalizumab is effective and well tolerated in patients with ulcerative colitis

July 9, 2002

Crucell licenses cell line to Korean company for HBV vaccine development

July 8, 2002

FDA approval for Remicade for remission maintenance of Crohn's disease

July 5, 2002

SkyePharma and GeneMedix to develop extended-release interferon alfa-2b

July 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...